📰 Dermasensor Inc News
Dermasensor Inc News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Dermasensor Inc. Real-time updates on events, politics, business and more.
February 16, 2024
The FDA has granted clearance for the first real-time, non-invasive skin cancer evaluation system .
January 29, 2024
The first medical device powered by artificial intelligence and designed to help doctors catch skin cancer has been approved by the U.S. Food and Drug Administration. The first medical device powered by artificial intelligence and designed to help doctors catch skin cancer has been approved by the U.S. Food and Drug Administration.
January 20, 2024
FDA approves DermaSensor, the first AI-powered medical device which can detect all major types of skin cancer! Get the full details.
January 20, 2024
The US FDA has approved DermaSensor, a medical apparatus powered by artificial intelligence, which can detect the most prevalent skin cancers.
January 19, 2024
Discover the FDA-approved DermaSensor, an AI-powered device revolutionizing skin cancer detection for patients over 40.
January 18, 2024
The handheld tool, intended for use by primary care physicians, uses spectroscopy and algorithms to evaluate skin lesions for potential cancer in a matter of seconds.
January 18, 2024
Dermasensor Inc. received U.S. FDA clearance for its non-invasive skin cancer evaluation device that provides quantitative identification of all skin cancer types at the point of care and within seconds. The point-and-click device is designed to facilitate detection of skin cancers by primary care physicians (PCPs) and speed the time to diagnosis and treatment.
January 18, 2024
The FDA has authorized the first artificial intelligence-powered medical device to help doctors detect the most common forms of skin cancer in patients.
January 18, 2024
The first medical device powered by artificial intelligence and designed to help doctors catch skin cancer has been approved by the U.S. Food and Drug Administration.
January 16, 2024
/PRNewswire/ -- Today, the U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency: Today, the FDA announced an...